ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 44 filers reported holding ONCOLYTICS BIOTECH INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $458 | -16.1% | 210 | 0.0% | 0.00% | – |
| Q2 2023 | $546 | +116.7% | 210 | 0.0% | 0.00% | – |
| Q1 2023 | $252 | -26.3% | 210 | 0.0% | 0.00% | – |
| Q4 2022 | $342 | – | 210 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 210 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 210 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 210 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 210 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 210 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 210 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 408,838 | $695,000 | 0.02% |
| Magnus Financial Group LLC | 10,000 | $17,000 | 0.00% |
| SCOTIA CAPITAL INC. | 48,039 | $83,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1,052 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 367 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 642 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HOWE & RUSLING INC | 105 | $0 | 0.00% |
| 1832 Asset Management L.P. | 5 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 4,601 | $7,000 | 0.00% |